Please login to read the full article.
Scrip Regulatory Affairs
Using an authorised representative in the EU - the duties and liabilities involved
14 March 2011
Mathias Klümper, Pascal Hofer
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- EU-wide consensus on confidential commercial data in drug marketing applications
- Big Pharma plans for compensating Indian trial deaths highlights need for guidelines
- Draft EU regulation sets out uniform conditions for various pharmacovigilance activities
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
